Cargando…
Commentary: Case report: Daratumumab treatment in pre-transplant alloimmunization and severe hemolytic anemia
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912978/ https://www.ncbi.nlm.nih.gov/pubmed/36776872 http://dx.doi.org/10.3389/fimmu.2023.1133382 |
_version_ | 1784885317667389440 |
---|---|
author | Jacobs, Jeremy W. Booth, Garrett S. Allen, Elizabeth S. Adkins, Brian D. |
author_facet | Jacobs, Jeremy W. Booth, Garrett S. Allen, Elizabeth S. Adkins, Brian D. |
author_sort | Jacobs, Jeremy W. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9912978 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99129782023-02-11 Commentary: Case report: Daratumumab treatment in pre-transplant alloimmunization and severe hemolytic anemia Jacobs, Jeremy W. Booth, Garrett S. Allen, Elizabeth S. Adkins, Brian D. Front Immunol Immunology Frontiers Media S.A. 2023-01-27 /pmc/articles/PMC9912978/ /pubmed/36776872 http://dx.doi.org/10.3389/fimmu.2023.1133382 Text en Copyright © 2023 Jacobs, Booth, Allen and Adkins https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Jacobs, Jeremy W. Booth, Garrett S. Allen, Elizabeth S. Adkins, Brian D. Commentary: Case report: Daratumumab treatment in pre-transplant alloimmunization and severe hemolytic anemia |
title | Commentary: Case report: Daratumumab treatment in pre-transplant alloimmunization and severe hemolytic anemia |
title_full | Commentary: Case report: Daratumumab treatment in pre-transplant alloimmunization and severe hemolytic anemia |
title_fullStr | Commentary: Case report: Daratumumab treatment in pre-transplant alloimmunization and severe hemolytic anemia |
title_full_unstemmed | Commentary: Case report: Daratumumab treatment in pre-transplant alloimmunization and severe hemolytic anemia |
title_short | Commentary: Case report: Daratumumab treatment in pre-transplant alloimmunization and severe hemolytic anemia |
title_sort | commentary: case report: daratumumab treatment in pre-transplant alloimmunization and severe hemolytic anemia |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912978/ https://www.ncbi.nlm.nih.gov/pubmed/36776872 http://dx.doi.org/10.3389/fimmu.2023.1133382 |
work_keys_str_mv | AT jacobsjeremyw commentarycasereportdaratumumabtreatmentinpretransplantalloimmunizationandseverehemolyticanemia AT boothgarretts commentarycasereportdaratumumabtreatmentinpretransplantalloimmunizationandseverehemolyticanemia AT allenelizabeths commentarycasereportdaratumumabtreatmentinpretransplantalloimmunizationandseverehemolyticanemia AT adkinsbriand commentarycasereportdaratumumabtreatmentinpretransplantalloimmunizationandseverehemolyticanemia |